Return to homepagePandemic Pact

to enable the optimization of anti-SARS-CoV-2 mAb candidates for developability and lowest cost of goods to produce a mAb product for the prevention of severe COVID-19 in vulnerable populations in low and middle income countries

Grant number: INV-006135

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020

  • Known Financial Commitments (USD)

    $1,944,053

  • Funder

    Gates Foundation

  • Research Location

    United States of America

  • Lead Research Institution

    Just-Evotec Biologics, Inc.

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    Innovation

  • Study Type

    Not applicable

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

N/A